Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow Quality Index
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow Quality Index of 4794.41x as of September 2025. Operating cash flow of CN¥281.88 Million exceeds net income of CN¥58.79K, indicating high earnings quality where cash backs reported profits. Explore 605033 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Shaanxi Meibang Pharmaceutical Group Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Shaanxi Meibang Pharmaceutical Group Co investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year earnings quality comparison for Shaanxi Meibang Pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see Shaanxi Meibang Pharmaceutical Group Co (605033) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 7.61x | CN¥280.40 Million | CN¥36.86 Million | ▲ +30.8% |
| 2023 | 5.82x | CN¥334.79 Million | CN¥57.56 Million | ▲ +567.6% |
| 2022 | 0.87x | CN¥126.41 Million | CN¥145.09 Million | ▲ +200.7% |
| 2021 | -0.86x | CN¥-108.75 Million | CN¥125.74 Million | ▼ -190.9% |
| 2020 | 0.95x | CN¥74.88 Million | CN¥78.73 Million | ▼ -43.5% |
| 2019 | 1.68x | CN¥128.45 Million | CN¥76.26 Million | ▲ +489.3% |
| 2018 | 0.29x | CN¥16.96 Million | CN¥59.33 Million | ▼ -40.5% |
| 2017 | 0.48x | CN¥29.41 Million | CN¥61.22 Million | — |